Microfluidics contribution to pharmaceutical sciences: From drug discovery to post marketing product management

Drug development process; Microfluidics; Miniaturization; Pharmaceutical sciences; Quality control; Review; Animals; Drug Discovery; Drug Industry; Humans

Abstract :

[en] Drug discovery and development is a long-lasting process in which many challenges have to be addressed at every stage, from the discovery of the target biomolecule to the commercialization of the discovered drugs and its quality control. From thousands of hits identified during early drug discovery only one drug is eventually efficient and safe enough to be commercialized. This high rejection rate, especially during preclinical and clinical studies have led to an exponential increase of costs to develop new medicines thereby strongly impacting healthcare systems. In this context, miniaturized devices have the potency to significantly reduce the cost and the time needed to develop new therapeutics by streamlining drug development and rejecting drug candidates earlier in the process prior to costly animal and human trials. In this review, we present recent advances involving miniaturized technologies in the field of drug discovery such as target discovery, drug screening, drug synthesis and formulation, in-vitro and in-vivo testing and quality control. We discuss opportunities enabled by miniaturized devices but also their limitations and challenges that need to be resolved in order to spread their use in the pharmaceutical industries. © 2018 Elsevier B.V.

Disciplines :

Pharmacy, pharmacology & toxicology

Author, co-author :

Nys, Gwenaël ; Université de Liège - ULiège > Département de pharmacie > Analyse des médicaments

Fillet, Marianne ; Université de Liège - ULiège > Département de pharmacie > Analyse des médicaments

Language :

English

Title :

Microfluidics contribution to pharmaceutical sciences: From drug discovery to post marketing product management

Publication date :

2018

Journal title :

Journal of Pharmaceutical and Biomedical Analysis

ISSN :

0731-7085

eISSN :

1873-264X

Publisher :

Elsevier, Amsterdam, Netherlands

Volume :

159

Pages :

348-362

Peer reviewed :

Peer Reviewed verified by ORBi

Available on ORBi :

since 13 January 2021

Statistics

Number of views

59 (2 by ULiège)

Number of downloads

5 (2 by ULiège)

More statistics

Scopus citations^®

Scopus citations^®
without self-citations

OpenCitations

Bibliography

Paul, S.M., et al. How to improve R&D productivity: the pharmaceutical industry's grand challenge. Nat. Rev. Drug Discov., 9(3), 2010, 203.
Rask-Andersen, M., Almén, M.S., Schiöth, H.B., Trends in the exploitation of novel drug targets. Nat. Rev. Drug Discov., 10(8), 2011, 579.
Schenone, M., et al. Target identification and mechanism of action in chemical biology and drug discovery. Nat. Chem. Biol., 9(4), 2013, 232.
Macarron, R., et al. Impact of high-throughput screening in biomedical research. Nat. Rev. Drug Discov., 10(3), 2011, 188.
Friedman, L.M., et al. Fundamentals of Clinical Trials. 2015, Springer.
Hay, M., et al. Clinical development success rates for investigational drugs. Nat. Biotechnol., 32(1), 2014, 40.
Sertkaya, A., et al. Key cost drivers of pharmaceutical clinical trials in the United States. Clin. Trials 13:2 (2016), 117–126.
Mould, D.R., Meibohm, B., Drug development of therapeutic monoclonal antibodies. BioDrugs 30:4 (2016), 275–293.
Wan, H., An overall comparison of small molecules and large biologics in ADME testing. ADMET DMPK 4:1 (2016), 1–22.
Mullard, A., FDA Drug Approvals. 2018. 2017, Nature Publishing Group.
Mullard, A., EMA Recommended 35 New Drugs in 2017. 2018, Nature Publishing Group.
Alkhatib, G., et al. CC CKR5: a RANTES, MIP-1α MIP-1 receptor as a fusion cofactor for macrophage-tropic HIV-1. Science (80-) 272:5270 (1996), 1955–1958.
Neužil, P., et al. Revisiting lab-on-a-chip technology for drug discovery. Nat. Rev. Drug Discovery, 11(8), 2012, 620.
Esch, E.W., Bahinski, A., Huh, D., Organs-on-chips at the frontiers of drug discovery. Nat. Rev. Drug Discovery, 14(4), 2015, 248.
Sackmann, E.K., Fulton, A.L., Beebe, D.J., The present and future role of microfluidics in biomedical research. Nature, 507(7491), 2014, 181.
Choi, K., et al. Digital microfluidics. Annu. Rev. Anal. Chem. 5 (2012), 413–440.
Croston, G.E., The utility of target-based discovery. Expert Opin. Drug Discovery 12:5 (2017), 427–429.
Thavandiran, N., et al. Design and formulation of functional pluripotent stem cell-derived cardiac microtissues. Proc. Natl. Acad. Sci. 110:49 (2013), E4698–E4707.
Hvichia, G.E., et al. A novel microfluidic platform for size and deformability based separation and the subsequent molecular characterization of viable circulating tumor cells. Int J Cancer 138:12 (2016), 2894–2904.
Lin, E., et al. High-throughput microfluidic labyrinth for the label-free isolation of circulating tumor cells. Cell Syst., 5(3), 2017 295-304e4.
Li, S., et al. An integrated platform for isolation, processing, and mass spectrometry-based proteomic profiling of rare cells in whole blood. Mol. Cell. Proteom. 14:6 (2015), 1672–1683.
Birch, C.M., et al. Identification of malaria parasite-infected red blood cell surface aptamers by inertial microfluidic SELEX (I-SELEX). Sci. Rep., 5, 2015, 11347.
Pereira, M.A., et al. Placental sequestration of plasmodium falciparum malaria parasites is mediated by the interaction between VAR2CSA and chondroitin sulfate a on syndecan-1. PLoS Pathog., 12(8), 2016, e1005831.
Song, J.W., et al. Microfluidic endothelium for studying the intravascular adhesion of metastatic breast cancer cells. PloS One, 4(6), 2009, e5756.
Lafleur, J.P., et al. Automated microfluidic sample-preparation platform for high-throughput structural investigation of proteins by small-angle X-ray scattering. J. Appl. Crystallogr. 44:5 (2011), 1090–1099.
Pham, N., et al. Coupling high throughput microfluidics and small-angle X-ray scattering to study protein crystallization from solution. Anal. Chem. 89:4 (2017), 2282–2287.
Hong, S., et al. Real-time analysis and direct observations of different superoxide dismutase (SOD1) molecules bindings to aggregates in temporal evolution step. Colloids Surf., B 101 (2013), 266–271.
Jecklin, M.C., et al. Label‐free determination of protein–ligand binding constants using mass spectrometry and validation using surface plasmon resonance and isothermal titration calorimetry. J. Mol. Recognit. 22:4 (2009), 319–329.
Domínguez-Vega, E., et al. Development of a surface plasmon resonance sensor for coupling to capillary electrophoresis allowing affinity assessment of protein mixture components. Sens. Actuators, B 254 (2018), 1040–1047.
Kopp, M.R., Arosio, P., Microfluidic approaches for the characterization of therapeutic proteins. J. Pharm. Sci., 2018.
Arosio, P., et al. Microfluidic diffusion analysis of the sizes and interactions of proteins under native solution conditions. ACS nano 10:1 (2015), 333–341.
Challa, P.K., et al. Real-time intrinsic fluorescence visualisation and sizing of proteins and protein complexes in microfluidic devices. Anal. Chem., 2018.
Zaman, H., et al. Characterisation of aggregates of cyclodextrin-drug complexes using Taylor dispersion analysis. Int. J. Pharm. 522:1-2 (2017), 98–109.
Chamieh, J., et al. Limits in size of Taylor dispersion analysis: representation of the different hydrodynamic regimes and application to the size-characterization of cubosomes. Anal. Chem. 89:24 (2017), 13487–13493.
Dawod, M., Arvin, N.E., Kennedy, R.T., Recent advances in protein analysis by capillary and microchip electrophoresis. Analyst 142:11 (2017), 1847–1866.
Štěpánová S., Kašička, V., Analysis of proteins and peptides by electromigration methods in microchips. J. Sep. Sci. 40:1 (2017), 228–250.
Merz, K.M. Jr, Ringe, D., Reynolds, C.H., Drug Design: Structure-and Ligand-Based Approaches. 2010, Cambridge University Press.
Mauser, H., Guba, W., Recent developments in de novo design and scaffold hopping. Curr. Opin. Drug Discov. Devel. 11:3 (2008), 365–374.
Klebe, G., Recent developments in structure-based drug design. J. Mol. Med. 78:5 (2000), 269–281.
Du, G., Fang, Q., den Toonder, J.M., Microfluidics for cell-based high throughput screening platforms—A review. Anal. Chim. Acta 903 (2016), 36–50.
van Duinen, V., et al. Microfluidic 3D cell culture: from tools to tissue models. Curr. Opin. Biotechnol. 35 (2015), 118–126.
Breslin, S., O'Driscoll, L., Three-dimensional cell culture: the missing link in drug discovery. Drug discovery today 18:5-6 (2013), 240–249.
Lanz, H.L., et al. Therapy response testing of breast cancer in a 3D high-throughput perfused microfluidic platform. BMC cancer, 17(1), 2017, 709.
Churski, K., et al. Rapid screening of antibiotic toxicity in an automated microdroplet system. Lab Chip 12:9 (2012), 1629–1637.
Mashaghi, S., van Oijen, A.M., Droplet microfluidics for kinetic studies of viral fusion. Biomicrofluidics, 10(2), 2016, 024102.
Wong, A.H.-H., et al. Drug screening of cancer cell lines and human primary tumors using droplet microfluidics. Sci. Rep., 7(1), 2017, 9109.
Zhao, S.-P., et al. Three-dimensional cell culture and drug testing in a microfluidic sidewall-attached droplet array. Anal. Chem. 89:19 (2017), 10153–10157.
Li, X., et al. Microfluidic platform with in-chip electrophoresis coupled to mass spectrometry for monitoring neurochemical release from nerve cells. Anal. Chem. 88:10 (2016), 5338–5344.
Kochhar, J., et al. Microfluidic devices for drug discovery and analysis. Microfluidic Devices for Biomedical Applications, 2013, Elsevier, 231–280.
Kang, L., et al. Microfluidics for drug discovery and development: from target selection to product lifecycle management. Drug discovery today 13:1-2 (2008), 1–13.
Herling, T.W., et al. A microfluidic platform for real-time detection and quantification of protein-ligand interactions. Biophys. J. 110:9 (2016), 1957–1966.
Shen, H., et al. Microfluidic-based G-quadruplex ligand displacement assay for alkaloid anticancer drug screening. J. Pharm. Biomed. Anal. 134 (2017), 333–339.
Farcaş E., et al. Partial filling affinity capillary electrophoresis as a useful tool for fragment-based drug discovery: a proof of concept on thrombin. Anal. Chim. Acta 984 (2017), 211–222.
Farcaş E., et al. Capillary electrophoresis in the context of drug discovery. J. Pharm. Biomed. Anal. 144 (2017), 195–212.
Hessel, V., Novel process windows–gate to maximizing process intensification via flow chemistry. Chem. Eng. Technol. 32:11 (2009), 1655–1681.
Malet-Sanz, L., Susanne, F., Continuous flow synthesis. A pharma perspective. J. Med. Chem. 55:9 (2012), 4062–4098.
Porta, R., Benaglia, M., Puglisi, A., Flow chemistry: recent developments in the synthesis of pharmaceutical products. Org. Process Res. Dev. 20:1 (2015), 2–25.
Pennemann, H., et al. Benchmarking of microreactor applications. Org. Process Res. Dev. 8:3 (2004), 422–439.
Elvira, K.S., i Solvas, X.C., Wootton, R.C., The past, present and potential for microfluidic reactor technology in chemical synthesis. Nat. Chem., 5(11), 2013, 905.
Rossi, S., et al. Continuous-flow stereoselective synthesis in microreactors: nucleophilic additions to nitrostyrenes organocatalyzed by a chiral bifunctional catalyst. J. Flow Chem. 5:1 (2015), 17–21.
Porta, R., et al. Enantioselective organocatalysis in microreactors: continuous flow synthesis of a (S)-pregabalin precursor and (S)-warfarin. Symmetry (Basel) 7:3 (2015), 1395–1409.
Gruber, P., et al. Enzymatic synthesis of chiral amino‐alcohols by coupling transketolase and transaminase‐catalyzed reactions in a cascading continuous‐flow microreactor system. Biotechnol. Bioeng. 115:3 (2018), 586–596.
Matesic, L., et al. Dose-on-demand production of diverse 18F-radiotracers for preclinical applications using a continuous flow microfluidic system. Nucl. Med. Biol. 52 (2017), 24–31.
Liang, S.H., et al. First human use of a radiopharmaceutical prepared by continuous-flow microfluidic radiofluorination: proof of concept with the tau imaging agent [18F] T807. Mol. Imaging, 13(8), 2014 p. 7290.2014. 00025.
Sanjay, S.T., et al. Recent advances of controlled drug delivery using microfluidic platforms. Adv. Drug Delivery Rev., 2017.
Stevenson, C.L., Santini, J.T. Jr, Langer, R., Reservoir-based drug delivery systems utilizing microtechnology. Adv. Drug Delivery Rev. 64:14 (2012), 1590–1602.
Choonara, Y.E., et al. A review of implantable intravitreal drug delivery technologies for the treatment of posterior segment eye diseases. J. Pharm. Sci. 99:5 (2010), 2219–2239.
Eljarrat-Binstock, E., Pe'er, J., Domb, A.J., New techniques for drug delivery to the posterior eye segment. Pharm. Res. 27:4 (2010), 530–543.
Yasin, M.N., et al. Implants for drug delivery to the posterior segment of the eye: a focus on stimuli-responsive and tunable release systems. J. Controlled Release 196 (2014), 208–221.
Lee, J.-H., et al. Design of an implantable device for ocular drug delivery. J. Drug Deliv., 2012.
Marsh, J., Pidaparti, R.M., Design optimization of an implantable device concept for passive ocular drug delivery. J. Med. Devices, 8(2), 2014, 021005.
Nuxoll, E., BioMEMS in drug delivery. Adv. Drug Delivery Rev. 65:11-12 (2013), 1611–1625.
Meng, E., Sheybani, R., Micro-and nano-fabricated implantable drug-delivery systems: current state and future perspectives. Ther. Deliv. 5:11 (2014), 1167–1170.
Farra, R., et al. First-in-human testing of a wirelessly controlled drug delivery microchip. Sci. Transl. Med., 4(122), 2012, 122ra21.
Zhuang, Y., et al. A MEMS-based electronic capsule for time controlled drug delivery in the alimentary canal. Sens. Actuators, A 169:1 (2011), 211–216.
Bawazer, L.A., et al. Combinatorial microfluidic droplet engineering for biomimetic material synthesis. Sci. Adv., 2(10), 2016, e1600567.
Guerzoni, L.P., et al. Microfluidic fabrication of polyethylene glycol microgel capsules with tailored properties for the delivery of biomolecules. Biomater. Sci. 5:8 (2017), 1549–1557.
Pessi, J., et al. Microfluidics-assisted engineering of polymeric microcapsules with high encapsulation efficiency for protein drug delivery. Int. J. Pharm. 472:1-2 (2014), 82–87.
Zhang, M.-J., et al. Microfluidic fabrication of monodisperse microcapsules for glucose-response at physiological temperature. Soft Matter 9:16 (2013), 4150–4159.
Yukuyama, M., et al. Nanoemulsion: process selection and application in cosmetics–a review. Int. J. Cosmet. Sci. 38:1 (2016), 13–24.
Uluata, S., Decker, E.A., McClements, D.J., Optimization of nanoemulsion fabrication using microfluidization: role of surfactant concentration on formation and stability. Food Biophys. 11:1 (2016), 52–59.
Salvia-Trujillo, L., et al. Physicochemical characterization and antimicrobial activity of food-grade emulsions and nanoemulsions incorporating essential oils. Food hydrocolloids 43 (2015), 547–556.
Ostertag, F., Weiss, J., McClements, D.J., Low-energy formation of edible nanoemulsions: factors influencing droplet size produced by emulsion phase inversion. J. Colloid Interface Sci. 388:1 (2012), 95–102.
Gao, Y., et al. Nanoemulsion enhances α-tocopherol succinate bioavailability in rats. Int. J. Pharm. 515:1-2 (2016), 506–514.
Ling Tan, S., et al. Nanoemulsion-based parenteral drug delivery system of carbamazepine: preparation, characterization, stability evaluation and blood-brain pharmacokinetics. Curr. Drug Deliv. 12:6 (2015), 795–804.
Chhabra, G., et al. Design and development of nanoemulsion drug delivery system of amlodipine besilate for improvement of oral bioavailability. Drug Dev. Ind. Pharm. 37:8 (2011), 907–916.
Yi, J., et al. Effects of lipids on in vitro release and cellular uptake of β-carotene in nanoemulsion-based delivery systems. J. Agric. Food. Chem. 63:50 (2015), 10831–10837.
Leung, A.K., et al. Lipid nanoparticles containing siRNA synthesized by microfluidic mixing exhibit an electron-dense nanostructured core. J. Phys. Chem. C 116:34 (2012), 18440–18450.
Yang, Z., et al. A microfluidic method to synthesize transferrin-lipid nanoparticles loaded with siRNA LOR-1284 for therapy of acute myeloid leukemia. Nanoscale 6:16 (2014), 9742–9751.
Dashtimoghadam, E., et al. Microfluidic self-assembly of polymeric nanoparticles with tunable compactness for controlled drug delivery. Polymer (Guildf) 54:18 (2013), 4972–4979.
Nys, G., et al. Beyond dried blood spot: current microsampling techniques in the context of biomedical applications. TrAC, Trends Anal. Chem., 2017.
Nowak, P., Woźniakiewicz, M., Kościelniak, P., Simulation of drug metabolism. TrAC, Trends Anal. Chem. 59 (2014), 42–49.
van den Brink, F.T., et al. Mass spectrometric detection of short-lived drug metabolites generated in an electrochemical microfluidic chip. Anal. Chem. 87:3 (2015), 1527–1535.
Ramana, P., et al. An improved design to capture magnetic microparticles for capillary electrophoresis based immobilized microenzyme reactors. Electrophoresis, 2018.
Schejbal, J., et al. On-line coupling of immobilized cytochrome P450 microreactor and capillary electrophoresis: a promising tool for drug development. J. Chromatogr. A 1437 (2016), 234–240.
Farcaş E., et al. Fully automated electrophoretically mediated microanalysis for CYP1A1 activity monitoring optimized by multivariate approach. Electrophoresis 37:2 (2016), 248–255.
Asensi‐Bernardi, L., et al. Fast evaluation of enantioselective drug metabolism by electrophoretically mediated microanalysis: application to fluoxetine metabolism by CYP2D6. Electrophoresis 34:22-23 (2013), 3214–3220.
Prantil-Baun, R., et al. Physiologically based pharmacokinetic and pharmacodynamic analysis enabled by microfluidically linked organs-on-chips. Annu. Rev. Pharmacool. Toxicol. 58 (2018), 37–64.
Wilmer, M.J., et al. Kidney-on-a-chip technology for drug-induced nephrotoxicity screening. Trends Biotechnol. 34:2 (2016), 156–170.
Yu, F., et al. Microfluidic platforms for modeling biological barriers in the circulatory system. Drug discovery today, 2018.
Wang, Y.I., Abaci, H.E., Shuler, M.L., Microfluidic blood–brain barrier model provides in vivo‐like barrier properties for drug permeability screening. Biotechnol. Bioeng. 114:1 (2017), 184–194.
Deosarkar, S.P., et al. A novel dynamic neonatal blood-brain barrier on a chip. PloS one, 10(11), 2015, e0142725.
Bricks, T., et al. Development of a new microfluidic platform integrating co-cultures of intestinal and liver cell lines. Toxicol. in Vitro 28:5 (2014), 885–895.
Vernetti, L.A., et al. A human liver microphysiology platform for investigating physiology, drug safety, and disease models. Exp. Biol. Med. 241:1 (2016), 101–114.
Kim, S., et al. Pharmacokinetic profile that reduces nephrotoxicity of gentamicin in a perfused kidney-on-a-chip. Biofabrication, 8(1), 2016, 015021.
Musah, S., et al. Mature induced-pluripotent-stem-cell-derived human podocytes reconstitute kidney glomerular-capillary-wall function on a chip. Nat. Biomed. Eng., 1(5), 2017, 0069.
Abaci, H.E., et al. Pumpless microfluidic platform for drug testing on human skin equivalents. Lab Chip 15:3 (2015), 882–888.
Jain, A., et al. Primary human lung alveolus‐on‐a‐chip model of intravascular thrombosis for assessment of therapeutics. Clin. Pharmacol. Ther. 103:2 (2018), 332–340.
Benam, K.H., et al. Matched-comparative modeling of normal and diseased human airway responses using a microengineered breathing lung chip. Cell Syst. 3:5 (2016), 456–466 e4.
Huh, D., Hamilton, G.A., Ingber, D.E., From 3D cell culture to organs-on-chips. Trends Cell Biol. 21:12 (2011), 745–754.
Coppeta, J., et al. A portable and reconfigurable multi-organ platform for drug development with onboard microfluidic flow control. Lab Chip 17:1 (2017), 134–144.
Maschmeyer, I., et al. A four-organ-chip for interconnected long-term co-culture of human intestine, liver, skin and kidney equivalents. Lab Chip 15:12 (2015), 2688–2699.
Lee, H., et al. A pumpless multi‐organ‐on‐a‐chip (MOC) combined with a pharmacokinetic–pharmacodynamic (PK–PD) model. Biotechnol. Bioeng. 114:2 (2017), 432–443.
Kimura, H., Sakai, Y., Fujii, T., Organ/Body-on-a-chip based on microfluidic technology for drug Discovery. Drug Metab. Pharmacokinet., 2017.
Atanasov, A.G., et al. Discovery and resupply of pharmacologically active plant-derived natural products: a review. Biotechnol. Adv. 33:8 (2015), 1582–1614.
Russell, W.M.S., Burch, R.L., Hume, C.W., The Principles of Humane Experimental Technique. 1959.
Kok, M.G., Fillet, M., Volumetric absorptive microsampling: current advances and applications. J. Pharm. Biomed. Anal., 2017.
Li, W., Tse, F.L., Dried blood spot sampling in combination with LC‐MS/MS for quantitative analysis of small molecules. Biomed. Chromatogr. 24:1 (2010), 49–65.
Thiry, J., et al. Sampling only ten microliters of whole blood for the quantification of poorly soluble drugs: itraconazole as case study. J. Chromatogr. A 1479 (2017), 161–168.
Thiry, J., et al. Bioavailability enhancement of itraconazole-based solid dispersions produced by hot melt extrusion in the framework of the Three Rs rule. Eur. J. Pharm. Sci. 99 (2017), 1–8.
Zhang, K., et al. Increased dissolution and oral absorption of itraconazole/Soluplus extrudate compared with itraconazole nanosuspension. Eur. J. Pharm. Biopharm. 85:3 (2013), 1285–1292.
Miller, M.A., et al. Flocculated amorphous itraconazole nanoparticles for enhanced in vitro supersaturation and in vivo bioavailability. Drug Dev. Ind. Pharm. 38:5 (2012), 557–570.
Mou, D., et al. Potent dried drug nanosuspensions for oral bioavailability enhancement of poorly soluble drugs with pH-dependent solubility. Int. J. Pharm. 413:1-2 (2011), 237–244.
Nys, G., et al. Whole blood microsampling for the quantitation of estetrol without derivatization by liquid chromatography-tandem mass spectrometry. J. Pharm. Biomed. Anal. 140 (2017), 258–265.
Valero, Y.C.G., et al. Clinical application of microsampling versus conventional sampling techniques in the quantitative bioanalysis of antibiotics: a systematic review. Bioanalysis 10:6 (2018), 407–423.
Parker, S.L., et al. Is there a role for microsampling in antibiotic pharmacokinetic studies?. Expert Opin. Drug Metab. Toxicol. 12:6 (2016), 601–614.
Chapman, K., et al. Overcoming the barriers to the uptake of nonclinical microsampling in regulatory safety studies. Drug discovery today 19:5 (2014), 528–532.
Verhaeghe, T., et al. The application of capillary microsampling in GLP toxicology studies. Bioanalysis 9:7 (2017), 531–540.
Gjelstad, A., Pedersen-Bjergaard, S., Electromembrane extraction: a new technique for accelerating bioanalytical sample preparation. Bioanalysis 3:7 (2011), 787–797.
Sarafraz-Yazdi, A., Amiri, A., Liquid-phase microextraction. TrAC, Trends Anal. Chem. 29:1 (2010), 1–14.
Ramos-Payan, M., Maspoch, S., Llobera, A., An effective microfluidic based liquid-phase microextraction device (μLPME) for extraction of non-steroidal anti-inflammatory drugs from biological and environmental samples. Anal. Chim. Acta 946 (2016), 56–63.
Kabir, A., Locatelli, M., Ulusoy, H.I., Recent trends in microextraction techniques employed in analytical and bioanalytical sample preparation. Separations, 4(4), 2017, 36.
Petersen, N.J., et al. On-chip electro membrane extraction. Microfluid. Nanofluid. 9:4-5 (2010), 881–888.
Pedersen-Bjergaard, S., Huang, C., Gjelstad, A., Electromembrane extraction–Recent trends and where to go. J. Pharm. Anal. 7:3 (2017), 141–147.
Asl, Y.A., Yamini, Y., Seidi, S., Development of a microfluidic-chip system for liquid–phase microextraction based on two immiscible organic solvents for the extraction and preconcentration of some hormonal drugs. Talanta 160 (2016), 592–599.
Drouin, N., Rudaz, S., Schappler, J., Dynamic-electromembrane extraction: a technical development for the extraction of neuropeptides. Anal. Chem. 88:10 (2016), 5308–5315.
Kumar, S., et al. Development of an integrated microfluidic solid-phase extraction and electrophoresis device. Analyst 141:5 (2016), 1660–1668.
Hilhorst, M., Briscoe, C., van de Merbel, N., Sense and nonsense of miniaturized LC–MS/MS for bioanalysis. Bioanalysis 6:24 (2014), 3263–3265.
Qu, J., Qu, Y., Straubinger, R.M., Ultra-sensitive quantification of corticosteroids in plasma samples using selective solid-phase extraction and reversed-phase capillary high-performance liquid chromatography/tandem mass spectrometry. Anal. Chem. 79:10 (2007), 3786–3793.
Fortier, M.-H., et al. Integrated microfluidic device for mass spectrometry-based proteomics and its application to biomarker discovery programs. Anal. Chem. 77:6 (2005), 1631–1640.
Hardouin, J., et al. Usefulness of an integrated microfluidic device (HPLC‐Chip‐MS) to enhance confidence in protein identification by proteomics. Rapid Commun. Mass Spectrom. 20:21 (2006), 3236–3244.
Groleau, P.E., et al. Low LC‐MS/MS detection of glycopeptides released from pmol levels of recombinant erythropoietin using nanoflow hplc‐chip electrospray ionization. J. Mass Spectrom. 43:7 (2008), 924–935.
Zolotarjova, N., et al. Combination of affinity depletion of abundant proteins and reversed-phase fractionation in proteomic analysis of human plasma/serum. J. Chromatogr. A 1189:1-2 (2008), 332–338.
Houbart, V., et al. Development of a nano-liquid chromatography on chip tandem mass spectrometry method for high-sensitivity hepcidin quantitation. J. Chromatogr. A 1218:50 (2011), 9046–9054.
Houbart, V., et al. Impact of injection solvent composition on protein identification in column-switching chip-liquid chromatography/mass spectrometry. J. Chromatogr. A 1445 (2016), 27–35.
Cobraiville, G., et al. Validation of a new method by nano-liquid chromatography on chip tandem mass spectrometry for combined quantitation of C3f and the V65 vitronectin fragment as biomarkers of diagnosis and severity of osteoarthritis. Talanta 169 (2017), 170–180.
Percy, A.J., et al. Comparison of standard-and nano-flow liquid chromatography platforms for MRM-based quantitation of putative plasma biomarker proteins. Anal. Bioanal.Chem. 404:4 (2012), 1089–1101.
Alley, W.R. Jr, et al. Chip-based reversed-phase liquid chromatography− mass spectrometry of permethylated N-linked glycans: a potential methodology for cancer-biomarker discovery. Anal. Chem. 82:12 (2010), 5095–5106.
Hua, S., et al. Isomer-specific chromatographic profiling yields highly sensitive and specific potential N-glycan biomarkers for epithelial ovarian cancer. J. Chromatogr. A 1279 (2013), 58–67.
Ruhaak, L.R., et al. Chip-based nLC-TOF-MS is a highly stable technology for large-scale high-throughput analyses. Anal. Bioanal.Chem. 405:14 (2013), 4953–4958.
Kantae, V., et al. Quantitative profiling of endocannabinoids and related N-acylethanolamines in human CSF using nano LC-MS/MS. J. Lipid Res. 58:3 (2017), 615–624.
Houbart, V., et al. A validated microfluidics‐based LC‐chip‐MS/MS method for the quantitation of fluoxetine and norfluoxetine in rat serum. Electrophoresis 33:22 (2012), 3370–3379.
Zhu, K.Y., et al. Microfluidic chip based nano liquid chromatography coupled to tandem mass spectrometry for the determination of abused drugs and metabolites in human hair. Anal. Bioanal.Chem. 402:9 (2012), 2805–2815.
Nys, G., et al. Comparison of nanofluidic and ultra-high performance liquid chromatography-tandem mass spectrometry for high sensitive pharmacokinetic studies of estrogens starting from whole blood microsampling. J. Chromatogr. A 1524 (2017), 160–168.
Heemskerk, A.A., et al. Ultra-low flow electrospray ionization-mass spectrometry for improved ionization efficiency in phosphoproteomics. Anal. Chem. 84:10 (2012), 4552–4559.
Juraschek, R., Dülcks, T., Karas, M., Nanoelectrospray—more than just a minimized-flow electrospray ionization source. J. Am. Soc. Mass. Spectrom. 10:4 (1999), 300–308.
Ahn, G., et al. Development and validation of a microfluidic chip-based nano-liquid chromatography–triple quadrupole tandem mass spectrometry method for a sensitive and reliable quantification of 7-ethyl-10-hydroxycamptothecin (SN38) in mouse plasma. Anal. Bioanal.Chem. 405:30 (2013), 9817–9824.
Chen, X., et al. Quantification of irinotecan, SN38, and SN38G in human and porcine plasma by ultra high-performance liquid chromatography–tandem mass spectrometry and its application to hepatic chemoembolization. J. Pharm. Biomed. Anal. 62 (2012), 140–148.
Goldwirt, L., et al. A new UPLC-MS/MS method for the determination of irinotecan and 7-ethyl-10-hydroxycamptothecin (SN-38) in mice: application to plasma and brain pharmacokinetics. J. Pharm. Biomed. Anal. 66 (2012), 325–333.
Roman, G.T., Murphy, J.P., Improving sensitivity and linear dynamic range of intact protein analysis using a robust and easy to use microfluidic device. Analyst 142:7 (2017), 1073–1083.
de Vries, R., et al. High sensitivity and selectivity in quantitative analysis of drugs in biological samples using 4-column multidimensional micro-UHPLC-MS enabling enhanced sample loading capacity. Anal. Chim. Acta 989 (2017), 104–111.
Quanico, J., et al. NanoLC-MS coupling of liquid microjunction microextraction for on-tissue proteomic analysis. Biochimica et Biophysica Acta (BBA)-Proteins and Proteomics 1865:7 (2017), 891–900.
Qi, L., et al. Quantitative proteomic analysis of host epithelial cells infected by salmonella enterica serovar typhimurium. Proteomics, 17(13-14), 2017, 1700092.
Anderson, L.C., et al. Analyses of histone proteoforms using front-end electron transfer dissociation-enabled orbitrap instruments. Mol. Cell. Proteom., 2016 p. mcp. O115. 053843.
Moreno-González, D., et al. Multi-residue pesticide analysis in virgin olive oil by nanoflow liquid chromatography high resolution mass spectrometry. J. Chromatogr. A, 2018.
Bailly-Chouriberry, L., et al. Use of split‐free nano‐liquid chromatography–mass spectrometry/high resolution mass spectrometry interface to improve the detection of α‐cobratoxin in equine plasma for doping control. Drug Test. Anal. 10:5 (2018), 880–885.
Futagami, S., et al. Preparation and evaluation of mesoporous silica layers on radially elongated pillars. J. Chromatogr. A 1523 (2017), 234–241.
Morbioli, G.G., et al. Recombinant drugs-on-a-chip: the usage of capillary electrophoresis and trends in miniaturized systems–a review. Anal. Chim. Acta 935 (2016), 44–57.
Creamer, J.S., Oborny, N.J., Lunte, S.M., Recent advances in the analysis of therapeutic proteins by capillary and microchip electrophoresis. Anal. Methods 6:15 (2014), 5427–5449.
Kinoshita, M., et al. Quality assurance of monoclonal antibody pharmaceuticals based on their charge variants using microchip isoelectric focusing method. J. Chromatogr. A 1309 (2013), 76–83.
Wheeler, T.D., et al. Microchip zone electrophoresis for high-throughput analysis of monoclonal antibody charge variants. Anal. Chem. 86:11 (2014), 5416–5424.
Han, H., Livingston, E., Chen, X., High throughput profiling of charge heterogeneity in antibodies by microchip electrophoresis. Anal. Chem. 83:21 (2011), 8184–8191.
Redman, E.A., et al. Characterization of intact antibody drug conjugate variants using microfluidic capillary electrophoresis–mass spectrometry. Anal. Chem. 88:4 (2016), 2220–2226.
Redman, E.A., et al. Integrated microfluidic capillary electrophoresis-electrospray ionization devices with online MS detection for the separation and characterization of intact monoclonal antibody variants. Anal. Chem. 87:4 (2015), 2264–2272.
Ha, N.S., Sadeghi, S., van Dam, R.M., Recent progress toward microfluidic quality control testing of radiopharmaceuticals. Micromachines (Basel), 8(11), 2017, 337.
Taggart, M.P., et al. Development of radiodetection systems towards miniaturised quality control of PET and SPECT radiopharmaceuticals. Lab Chip 16:9 (2016), 1605–1616.
Ly, J., et al. Toward miniaturized analysis of chemical identity and purity of radiopharmaceuticals via microchip electrophoresis. Anal. Bioanal.Chem. 410:9 (2018), 2423–2436.
Beebe, D.J., Mensing, G.A., Walker, G.M., Physics and applications of microfluidics in biology. Annu. Rev. Biomed. Eng. 4:1 (2002), 261–286.
Chandrasekaran, A., Abduljawad, M., Moraes, C., Have microfluidics delivered for drug discovery?. Expert Opin. Drug Discovery 11:8 (2016), 745–748.
Schneider, G., Automating drug discovery. Nat. Rev. Drug Discovery, 2017.
Ahn, J., et al. Microfluidics in nanoparticle drug delivery; From synthesis to pre-clinical screening. Adv. Drug Delivery Rev., 2018.